Achilles Therapeutics’ £52.7 Million Series C Funding Round

Paolo Bossi

Goodwin Procter LLP advised Achilles Therapeutics on the deal. Achilles Therapeutics announced the completion of a £52.7 million oversubscribed Series C funding round. OrbiMed, Boxer Capital…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now